PURPOSE We investigated erectile and ejaculatory function after penile prosthesis implantation. MATERIALS AND METHODS A total of 121 patients were enrolled in the surgery group (SG) and 120 patients in the nonsurgery group (NSG). All subjects were evaluated by use of the following questionnaires: the erection function and intercourse satisfaction domains of the International Index of Erectile...

OBJECTIVE We created the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) because the current lack of psychometrically sound inventories for measuring these dimensions of cannabis use has impeded research on the effects of cannabis in humans. METHOD A sample of 2,062 cannabis users completed the DFAQ-CU and was used to assess the DFAQ-CU's factor struc...

Abstract Introduction The Prostatic Urethral Lift (PUL) is the most thoroughly studied minimally invasive surgical therapy (MIST) for BPH with over 300 patients in a controlled trial setting. Objective In this combined analysis from 5 PUL studies we examine meta-effect of procedure on outcomes including sexual function and proportion subjects who move higher to lower IPSS symptom severity grade...

Abstract Introduction For the past several years, AUA has recommended PUL as a treatment option for eligible patients who desire preservation of erectile and ejaculatory function. Objective This analysis serves first detailed assessment sexual function symptom outcomes among treated with PUL, TURP or sham in controlled real-world studies PUL. Methods Outcomes including MSHQ bother scores were c...

Abstract Introduction Antegrade ejaculation is a fundamental aspect of sexual satisfaction for many individuals, but retrograde (RE) occurs in up to 75 % some surgical treatments benign prostatic hyperplasia. Unfortunately, clinicians commonly focus only primarily on erection strength, and existing tools inadequately characterize rates bother associated with RE after BPH treatment. Objective Th...

INTRODUCTION Benign prostatic hyperplasia (BPH) causes disorders of voiding and sexual function. Phar- macologic therapy reduces symptoms of voiding thus impacting sexual function. OBJECTIVE To determine sex life status in men with BPH before and after pharmacologic treatment adapted to achieve satisfactory sexual function. METHODS We studied 117 sexually active BPH patients, not previously...

Treatment of patients with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) may affect the quality of sexual function and ejaculation. The effect of new surgical procedures, which are currently available to treat BPH, on erection and ejaculation, has been poorly studied. This study aimed to assess the effect of thulium laser enucleation of the prostate (ThuLEP...

INTRODUCTION The development of effective medications makes pharmacological therapy of BPH the dominant mode of treatment today. It improves urinary symptoms and prevents disease progression while producing side effects on male sexual function. OBJECTIVE The aim of the study is to present the effects of BPH pharmacological treatment on the occurrence of sexually adverse effects in men: change...

You have accessJournal of UrologyTrauma/Reconstruction/Diversion: Urethral Reconstruction (including Stricture, Diverticulum) I (MP03)1 Sep 2021MP03-16 LONG-TERM FOLLOW-UP SUGGESTS HIGH SATISFACTION RATES FOR BULBOMEMBRANOUS RADIATION INDUCED URETHRAL STRICTURES TREATED WITH ANASTOMOTIC URETHROPLASTY John Barnard, Aron Liaw, and Joel Gelman BarnardJohn Barnard More articles by this author , Lia...